跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Brelta 15 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Brelta 15
Approved
STANDARD
Brelta 15
Inventia Healthcare Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fe2c64c3ce74c83e
Company
Inventia Healthcare Limited
Type
Standard
Approval Details
Approval Id
fe2c64c3ce74c83e
Drug Approval Philippines Name
Brelta 15
Product Name
Brelta 15
Registration Number
DRP-15203
Brand Name
Brelta 15
Generic Name
Rivaroxaban
Dosage Form
Film-Coated Tablet
Dosage Strength
15 mg
Manufacturer
Inventia Healthcare Limited
Importer
Bliss Pharma Distribution and Consultancy Corp.
Distributor
Bliss Pharma Distribution and Consultancy Corp.
Company Detail Path
/organization/inventia-healthcare-limited
Issuance Date
24 May 2024
Expiry Date
24 May 2029
Pharmacologic Category
Antithrombotic agent (Direct factor Xa inhibitor)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fe2c64c3ce74c83e
Type
Standard
Back to Philippines FDA Approvals